For much of the pandemic, variant sequencing in the U.S. has been piecemeal, spread between academic research labs, hospitals, philanthropist-funded nonprofits, state health departments, and rare commercial participants.

Bloomberg's Mark Leydorf reads "Hunting Delta" from Bloomberg Businessweek.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.